
    
      The investigators propose to enroll CVD and healthy subjects between 30 and 60 years of age,
      matched for age, gender, body mass index, and medication (statin and anti-hypertensive) use.
      Circulating endothelial progenitor cells will be isolated from blood and cultured in vitro to
      differentiate into endothelial cells.
    
  